⚠️ The process described below is subject to change
Introduction
PRISMA: Personalised RISk-based MAmmascreening
Aim: Assess whether introduction of risk-based screening in the Netherlands would improve balance between benefits and harms of breast cancer screening
Data collection between 2014-2019:
67,000 (un)processed mammograms
38,000 health questionnaires
10,100 blood samples
600 saliva samples
Linked to Dutch Cancer Registry to identify breast cancer cases
Approach for onboarding
Initially, the aim will be to make PRISMA available in the National Catalogue. Further steps will depend on both the FAIRification objectives of PRISMA and the plateau planning. For example, in plateau 2 the metadata will be extended beyond the Core schema and PRISMA could thus add the additional metadata in the future. As such, the PRISMA use case will be revisited in the upcoming years.
If possible, we should refer to existing general scenarios.
Step 1 Make PRISMA Findable in in the National Catalogue - Core
See Scenario RUMC1.1: Make Dataset Findable in HRI Catalogue - Core